GeoVax Labs (GOVX) Cash from Operations (2010 - 2025)
GeoVax Labs (GOVX) posted quarterly Cash from Operations of 4961776.0 for Q4 2025, up 36.01% year-over-year from 3648193.1 in Q4 2024, and up 20.13% quarter-over-quarter from 6212115.0 in Q3 2025.
GeoVax Labs (GOVX) Cash from Operations (2010 - 2025) Analysis & Trends
GeoVax Labs (GOVX) has reported Cash from Operations for 16 consecutive years, with 4961776.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Cash from Operations rose 36.01% year-over-year to 4961776.0; the TTM figure through Dec 2025 stood at 21473969.0 (up 12.97% YoY), while the FY2025 annual figure was 21473969.0, up 12.97% from the prior year.
- Cash from Operations advanced to 4961776.0 in Q4 2025 per GOVX's latest filing, from 6212115.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 1258539.0 in Q2 2021 and bottomed at 10277945.0 in Q4 2023.
- Historically, Cash from Operations has averaged 5077487.35 across 5 years, with a median of 5028727.0 in 2023.
- Annual changes were most pronounced in 2021 — Cash from Operations slumped 477.02% — and 2024, when it jumped 67.85%.
- GeoVax Labs' Cash from Operations stood at 6683149.0 in 2021, then slipped by 5.7% to 7064236.0 in 2022, then slumped by 45.49% to 10277945.0 in 2023, then gained by 24.56% to 7753550.0 in 2024, then surged by 36.01% to 4961776.0 in 2025.
- Business Quant data shows GOVX's Cash from Operations at 4961776.0 in Q4 2025, 6212115.0 in Q3 2025, and 4334398.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | GeoVax Labs | 2.88 Mn | -260,493.75 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.96 Mn |
| Dec 31, 2025 | -4.96 Mn |
| Sep 30, 2025 | -6.21 Mn |
| Sep 30, 2025 | -6.21 Mn |
| Jun 30, 2025 | -4.33 Mn |
| Jun 30, 2025 | -4.33 Mn |
| Mar 31, 2025 | -5.97 Mn |
| Mar 31, 2025 | -5.97 Mn |
| Dec 31, 2024 | -7.75 Mn |
| Dec 31, 2024 | -7.75 Mn |
| Sep 30, 2024 | -9.30 Mn |
| Sep 30, 2024 | -9.30 Mn |
| Jun 30, 2024 | -1.94 Mn |
| Jun 30, 2024 | -1.94 Mn |
| Mar 31, 2024 | -5.68 Mn |
| Mar 31, 2024 | -5.68 Mn |
| Dec 31, 2023 | -10.28 Mn |
| Dec 31, 2023 | -10.28 Mn |
| Sep 30, 2023 | -5.10 Mn |
| Sep 30, 2023 | -5.10 Mn |